Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Synergistic effects of PRIMA-1Met (APR-246) and Azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia.

Maslah N, Salomao N, Drevon L, Verger E, Partouche N, Ly P, Aubin P, Naoui N, Schlageter MH, Bally C, Miekoutima E, Rahmé R, Lehmann-Che J, Ades L, Fenaux P, Cassinat B, Giraudier S.

Haematologica. 2019 Sep 5. pii: haematol.2019.218453. doi: 10.3324/haematol.2019.218453. [Epub ahead of print]

2.

Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses.

Maslah N, Soret J, Dosquet C, Vercellino L, Belkhodja C, Schlageter MH, Cassinat B, Kiladjian JJ, Chomienne C, Giraudier S.

Haematologica. 2020 Mar;105(3):e95-e97. doi: 10.3324/haematol.2018.215582. Epub 2019 Aug 14. No abstract available.

3.

Practicability of a locking plate for difficult pathologies of the scaphoid.

Mehling IM, Arsalan-Werner A, Wingenbach V, Seegmüller J, Schlageter M, Sauerbier M.

Arch Orthop Trauma Surg. 2019 Aug;139(8):1161-1169. doi: 10.1007/s00402-019-03196-6. Epub 2019 May 23.

PMID:
31123820
4.

Long-term outcome of fingertip reconstruction with the homodigital neurovascular island flap.

Arsalan-Werner A, Brui N, Mehling I, Schlageter M, Sauerbier M.

Arch Orthop Trauma Surg. 2019 Aug;139(8):1171-1178. doi: 10.1007/s00402-019-03198-4. Epub 2019 May 21.

PMID:
31115665
5.

Next-generation sequencing for JAK2 mutation testing: advantages and pitfalls.

Maslah N, Verger E, Schlageter MH, Miclea JM, Kiladjian JJ, Giraudier S, Chomienne C, Cassinat B.

Ann Hematol. 2019 Jan;98(1):111-118. doi: 10.1007/s00277-018-3499-y. Epub 2018 Sep 26.

PMID:
30259120
6.

Successful Treatment of Differentiated Thyroid Carcinoma with Transaxillary Robotic Surgery and Radioiodine: The First European Experience.

Balay MA, Aidan P, Schlageter MH, Georges O, Meas T, Bechara M, Toubert ME, Faugeron I, Monpeyssen H, Chougnet CN.

Eur Thyroid J. 2018 Jun;7(3):149-154. doi: 10.1159/000487234. Epub 2018 Feb 21.

7.

Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review.

Lamy PJ, Allory Y, Gauchez AS, Asselain B, Beuzeboc P, de Cremoux P, Fontugne J, Georges A, Hennequin C, Lehmann-Che J, Massard C, Millet I, Murez T, Schlageter MH, Rouvière O, Kassab-Chahmi D, Rozet F, Descotes JL, Rébillard X.

Eur Urol Focus. 2018 Dec;4(6):790-803. doi: 10.1016/j.euf.2017.02.017. Epub 2017 Mar 7.

PMID:
28753865
8.

Thyroglobulin assay in fluids from lymph node fine needle-aspiration washout: influence of pre-analytical conditions.

Casson FB, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C.

Ann Biol Clin (Paris). 2017 Apr 1;75(2):173-180. doi: 10.1684/abc.2017.1225.

9.

Liver damage and senescence increases in patients developing hepatocellular carcinoma.

Rey S, Quintavalle C, Burmeister K, Calabrese D, Schlageter M, Quagliata L, Cathomas G, Diebold J, Molinolo A, Heim MH, Terracciano LM, Matter MS.

J Gastroenterol Hepatol. 2017 Aug;32(8):1480-1486. doi: 10.1111/jgh.13717.

PMID:
28052383
10.

Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.

Vignon M, Andreoli A, Dhédin N, Lengliné E, Masson E, Robin M, Granier C, Larghero J, Schlageter MH, de Latour RP, Socié G, Boissel N.

J Adolesc Young Adult Oncol. 2017 Jun;6(2):299-306. doi: 10.1089/jayao.2016.0060. Epub 2016 Dec 16.

PMID:
27983886
11.

Relevance of serum biomarkers associated with melanoma during follow-up of anti-CTLA-4 immunotherapy.

Felix J, Cassinat B, Porcher R, Schlageter MH, Maubec E, Pages C, Baroudjian B, Homyrda L, Boukouaci W, Tamouza R, Bagot M, Caignard A, Toubert A, Lebbé C, Moins-Teisserenc H.

Int Immunopharmacol. 2016 Nov;40:466-473. doi: 10.1016/j.intimp.2016.09.030. Epub 2016 Oct 8.

PMID:
27728898
12.

Clinicopathological Features and Metastatic Pattern of Hepatocellular Carcinoma: An Autopsy Study of 398 Patients.

Schlageter M, Quagliata L, Matter M, Perrina V, Tornillo L, Terracciano L.

Pathobiology. 2016;83(6):301-7. doi: 10.1159/000446245. Epub 2016 Jun 18.

13.

High-flexibility combinatorial peptide synthesis with laser-based transfer of monomers in solid matrix material.

Loeffler FF, Foertsch TC, Popov R, Mattes DS, Schlageter M, Sedlmayr M, Ridder B, Dang FX, von Bojničić-Kninski C, Weber LK, Fischer A, Greifenstein J, Bykovskaya V, Buliev I, Bischoff FR, Hahn L, Meier MA, Bräse S, Powell AK, Balaban TS, Breitling F, Nesterov-Mueller A.

Nat Commun. 2016 Jun 14;7:11844. doi: 10.1038/ncomms11844.

14.

Why a standard contrast-enhanced MRI might be useful in intracranial internal carotid artery stenosis.

Oeinck M, Rozeik C, Wattchow J, Meckel S, Schlageter M, Beeskow C, Reinhard M.

Neuroradiol J. 2016 Jun;29(3):208-12. doi: 10.1177/1971400916638354. Epub 2016 Mar 17.

15.

pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice.

Patel S, Guerenne L, Gorombei P, Omidvar N, Schlageter MH, Alex AA, Ganesan S, West R, Adès L, Mathews V, Krief P, Pla M, Fenaux P, Chomienne C, Padua RA.

Blood Cancer J. 2015 Dec 11;5:e374. doi: 10.1038/bcj.2015.102. No abstract available.

16.

Effect of Ligand Field Tuning on the SMM Behavior for Three Related Alkoxide-Bridged Dysprosium Dimers.

Peng Y, Mereacre V, Baniodeh A, Lan Y, Schlageter M, Kostakis GE, Powell AK.

Inorg Chem. 2016 Jan 4;55(1):68-74. doi: 10.1021/acs.inorgchem.5b01793. Epub 2015 Dec 11.

PMID:
26652937
17.

Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations.

Verger E, Cassinat B, Chauveau A, Dosquet C, Giraudier S, Schlageter MH, Ianotto JC, Yassin MA, Al-Dewik N, Carillo S, Legouffe E, Ugo V, Chomienne C, Kiladjian JJ.

Blood. 2015 Dec 10;126(24):2585-91. doi: 10.1182/blood-2015-07-659060. Epub 2015 Oct 20.

PMID:
26486786
18.

DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies.

Le Pogam C, Patel S, Gorombei P, Guerenne L, Krief P, Omidvar N, Tekin N, Bernasconi E, Sicre F, Schlageter MH, Chopin M, Noguera ME, West R, Abu A, Mathews V, Pla M, Fenaux P, Chomienne C, Padua RA.

Oncotarget. 2015 Oct 20;6(32):32494-508. doi: 10.18632/oncotarget.5572.

19.

The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profile.

Szalat R, Monsel G, Le Goff W, Battistella M, Bengouffa D, Schlageter MH, Bouaziz JD, Arnulf B, Vignon M, Lesnik P, Saussine A, Malphettes M, Lazareth A, Vignon-Pennamen MD, Bagot M, Brouet JC, Fermand JP, Rybojad M, Asli B.

J Am Acad Dermatol. 2015 Nov;73(5):809-20. doi: 10.1016/j.jaad.2015.07.031. Epub 2015 Sep 11. Review.

PMID:
26365596
20.

Letter to the editor: a case of an extraadrenal paraganglioma in the sigma in a patient with recurrent sigmadiverticulitis.

Tampakis A, Schlageter M, Oertli D, Misteli H.

Int J Colorectal Dis. 2016 Mar;31(3):729-31. doi: 10.1007/s00384-015-2234-6. Epub 2015 May 21. No abstract available.

PMID:
25994781
21.

Histopathology of hepatocellular carcinoma.

Schlageter M, Terracciano LM, D'Angelo S, Sorrentino P.

World J Gastroenterol. 2014 Nov 21;20(43):15955-64. doi: 10.3748/wjg.v20.i43.15955. Review.

22.

Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone.

Hamy AS, Porcher R, Cuvier C, Giacchetti S, Schlageter MH, Coussieu C, Gronier H, Feugeas JP, Adoui N, Lacorte JM, Poirot C, Habdous M, Espié M.

Reprod Biomed Online. 2014 Nov;29(5):573-80. doi: 10.1016/j.rbmo.2014.07.008. Epub 2014 Jul 28.

PMID:
25246112
23.

Evaluation of a new thyroglobulin sensitive assay in patients with differentiated thyroid cancer.

Schlageter MH, Toubert ME, Meas T, Bouhassira E, Faugeron I, Vimont V, Thomas E, Theimer C, Chomienne C.

Clin Chem Lab Med. 2015 Feb;53(2):e41-3. doi: 10.1515/cclm-2014-0662. No abstract available.

PMID:
25153604
24.

[An interview in the indoor climbing gym -- wall athletes].

Schlageter M, Schwarz J.

Sportverletz Sportschaden. 2014 Jun;28(2):62-6. doi: 10.1055/s-0034-1384245. Epub 2014 Jun 25. German. No abstract available.

PMID:
24963736
25.

An unexpected cause of diffuse alveolar hemorrhage in a kidney transplant patient.

Schlageter M, Jahn KD, Tzankov A, Wiese M, Bubendorf L, Tamm M, Savic S.

Respiration. 2014;87(6):504-7. doi: 10.1159/000358566. Epub 2014 Apr 10.

26.

Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA).

Quagliata L, Schlageter M, Quintavalle C, Tornillo L, Terracciano LM.

Microarrays (Basel). 2014 Apr 15;3(2):91-102. doi: 10.3390/microarrays3020091. Review.

27.

Automated two-site immunofluorescent assay for the measurement of serum chromogranin A.

Popovici T, Moreira B, Schlageter MH, Bories PN.

Clin Biochem. 2014 Jan;47(1-2):87-91. doi: 10.1016/j.clinbiochem.2013.10.029. Epub 2013 Nov 5.

PMID:
24201067
28.

Development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia.

Menter T, Schlageter M, Bastian L, Haberthür R, Rätz Bravo AE, Tzankov A.

Hematol Oncol. 2014 Mar;32(1):47-51. doi: 10.1002/hon.2054. Epub 2013 Apr 29.

PMID:
23625339
29.

[Saphenous perforator flap].

Winkel R, Tajsic N, Husum H, Schlageter M, Hanebuth G, Hoffmann R.

Oper Orthop Traumatol. 2013 Apr;25(2):152-61. doi: 10.1007/s00064-012-0198-z. German.

PMID:
23519297
30.

Hypoxia imaging of uterine cervix carcinoma with (18)F-FETNIM PET/CT.

Vercellino L, Groheux D, Thoury A, Delord M, Schlageter MH, Delpech Y, Barré E, Baruch-Hennequin V, Tylski P, Homyrda L, Walker F, Barranger E, Hindié E.

Clin Nucl Med. 2012 Nov;37(11):1065-8. doi: 10.1097/RLU.0b013e3182638e7e.

PMID:
22996235
31.

Coexistence of a myeloproliferative disorder and secondary polycythemia in the same patient.

Kouroupi E, Cassinat B, Schlageter MH, Dosquet C, Kiladjian JJ, Chomienne C.

Am J Hematol. 2012 Jun;87(6):646. doi: 10.1002/ajh.23185. Epub 2012 Mar 31. No abstract available. Erratum in: Am J Hematol. 2012 Jul;87(7):748. Cassinat, Bruno [added]; Schlageter, Marie-Helene [added]; Dosquet, Christine [added]; Kiladjian, Jean-Jacques [added]; Chomienne, Christine [added].

32.

Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy.

Blanchard P, Quero L, Pacault V, Schlageter MH, Baruch-Hennequin V, Hennequin C.

BMC Cancer. 2012 Mar 26;12:119. doi: 10.1186/1471-2407-12-119.

33.

Topical nasal steroid treatment does not improve CPAP compliance in unselected patients with OSAS.

Strobel W, Schlageter M, Andersson M, Miedinger D, Chhajed PN, Tamm M, Leuppi JD.

Respir Med. 2011 Feb;105(2):310-5. doi: 10.1016/j.rmed.2010.10.003. Epub 2010 Dec 3.

34.

A concise summary of experimental facts about the Soai reaction.

Gehring T, Busch M, Schlageter M, Weingand D.

Chirality. 2010;22 Suppl 1:E173-82. doi: 10.1002/chir.20849.

PMID:
21038388
35.

[NITINOL shape memory staple for osteosynthesis of the scaphoid].

Winkel R, Schlageter M.

Oper Orthop Traumatol. 2009 Nov;21(4-5):361-72. doi: 10.1007/s00064-009-1910-5. German.

PMID:
20058116
36.

Systematic studies using 2-(1-adamantylethynyl)pyrimidine-5-carbaldehyde as a starting material in Soai's asymmetric autocatalysis.

Busch M, Schlageter M, Weingand D, Gehring T.

Chemistry. 2009 Aug 17;15(33):8251-8. doi: 10.1002/chem.200900634.

PMID:
19585641
37.

When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).

Cassinat B, de Botton S, Kelaidi C, Ades L, Zassadowski F, Guillemot I, Schlageter MH, Raffoux E, Harousseau JL, Legrand O, Escoffre-Barbe M, Reman O, Gardembas M, Himberlin C, Cahn JY, Guyotat D, Bouscary D, Parry A, Rousselot P, Baruchel A, Dombret H, Chevret S, Fenaux P, Chomienne C.

Leuk Res. 2009 Sep;33(9):1178-82. doi: 10.1016/j.leukres.2008.12.010. Epub 2009 Jan 23.

PMID:
19167754
38.

Therapy-resistant anaemia in congenital nephrotic syndrome of the Finnish type--implication of EPO, transferrin and transcobalamin losses.

Toubiana J, Schlageter MH, Aoun B, Dunand O, Vitkevic R, Bensman A, Ulinski T.

Nephrol Dial Transplant. 2009 Apr;24(4):1338-40. doi: 10.1093/ndt/gfn762. Epub 2009 Jan 18.

PMID:
19153070
39.

Auer rods and differentiation in acute promyelocytic leukemia.

Zassadowski F, Ades L, Schlageter MH, Chevret S, Guillemot I, Fenaux P, Chomienne C, Cassinat B.

Br J Haematol. 2008 Sep;142(6):998-1000. doi: 10.1111/j.1365-2141.2008.07282.x. Epub 2008 Jun 9. No abstract available.

PMID:
18544082
40.

Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients.

Kouroupi E, Zoi K, Parquet N, Zoi C, Kiladjian JJ, Grigoraki V, Vainchenker W, Lellouche F, Marzac C, Schlageter MH, Dosquet C, Scott LM, Fenaux P, Loukopoulos D, Chomienne C, Cassinat B.

Br J Haematol. 2008 Aug;142(4):676-9. doi: 10.1111/j.1365-2141.2008.07223.x. Epub 2008 May 22. No abstract available.

PMID:
18503583
41.

Stem cell mobilization in idiopathic steroid-sensitive nephrotic syndrome.

Lapillonne H, Leclerc A, Ulinski T, Balu L, Garnier A, Dereuddre-Bosquet N, Watier H, Schlageter MH, Deschênes G.

Pediatr Nephrol. 2008 Aug;23(8):1251-6. doi: 10.1007/s00467-008-0793-2. Epub 2008 May 6.

PMID:
18458957
42.

Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients.

Schlumberger M, Hitzel A, Toubert ME, Corone C, Troalen F, Schlageter MH, Claustrat F, Koscielny S, Taieb D, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Torlontano M, Tenenbaum F, Bardet S, Bussière F, Girard JJ, Morel O, Schneegans O, Schlienger JL, Prost A, So D, Archambeaud F, Ricard M, Benhamou E.

J Clin Endocrinol Metab. 2007 Jul;92(7):2487-95. Epub 2007 Apr 10.

PMID:
17426102
43.

Frequent antibody production against RARalpha in both APL mice and patients.

Robin M, Andreu-Gallien J, Schlageter MH, Bengoufa D, Guillemot I, Pokorna K, Robert C, Larghero J, Rousselot P, Raffoux E, Dombret H, Fenaux P, Pla M, Charron D, Padua RA, Chomienne C.

Blood. 2006 Sep 15;108(6):1972-4. Epub 2006 May 25.

PMID:
16728697
44.

Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring.

Luton D, Le Gac I, Vuillard E, Castanet M, Guibourdenche J, Noel M, Toubert ME, Léger J, Boissinot C, Schlageter MH, Garel C, Tébeka B, Oury JF, Czernichow P, Polak M.

J Clin Endocrinol Metab. 2005 Nov;90(11):6093-8. Epub 2005 Aug 23.

PMID:
16118343
45.

Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.

Robin M, Schlageter MH, Chomienne C, Padua RA.

Cancer Immunol Immunother. 2005 Oct;54(10):933-43. Epub 2005 May 12. Review.

PMID:
15889256
46.

Farnesyltransferase inhibitor tipifarnib (R115777) preferentially inhibits in vitro autonomous erythropoiesis of polycythemia vera patient cells.

Larghero J, Gervais N, Cassinat B, Rain JD, Schlageter MH, Padua RA, Chomienne C, Rousselot P.

Blood. 2005 May 1;105(9):3743-5. Epub 2005 Jan 4.

PMID:
15632209
47.

Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

Thervet E, Anglicheau D, King B, Schlageter MH, Cassinat B, Beaune P, Legendre C, Daly AK.

Transplantation. 2003 Oct 27;76(8):1233-5.

PMID:
14578760
48.

PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia.

Padua RA, Larghero J, Robin M, le Pogam C, Schlageter MH, Muszlak S, Fric J, West R, Rousselot P, Phan TH, Mudde L, Teisserenc H, Carpentier AF, Kogan S, Degos L, Pla M, Bishop JM, Stevenson F, Charron D, Chomienne C.

Nat Med. 2003 Nov;9(11):1413-7. Epub 2003 Oct 19.

PMID:
14566333
49.

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation.

Anglicheau D, Flamant M, Schlageter MH, Martinez F, Cassinat B, Beaune P, Legendre C, Thervet E.

Nephrol Dial Transplant. 2003 Nov;18(11):2409-14.

PMID:
14551375
50.

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients.

Anglicheau D, Verstuyft C, Laurent-Puig P, Becquemont L, Schlageter MH, Cassinat B, Beaune P, Legendre C, Thervet E.

J Am Soc Nephrol. 2003 Jul;14(7):1889-96.

Supplemental Content

Loading ...
Support Center